IRIS
CAVESTRO, Giulia Martina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.135
AS - Asia 5.378
EU - Europa 3.908
SA - Sud America 716
AF - Africa 305
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 16.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.951
SG - Singapore 2.188
CN - Cina 1.492
VN - Vietnam 773
SE - Svezia 650
IE - Irlanda 622
BR - Brasile 542
UA - Ucraina 531
IT - Italia 518
FI - Finlandia 435
DE - Germania 416
HK - Hong Kong 367
TR - Turchia 218
ZA - Sudafrica 210
FR - Francia 182
NL - Olanda 172
GB - Regno Unito 135
CA - Canada 119
RU - Federazione Russa 95
AR - Argentina 74
CI - Costa d'Avorio 54
IN - India 50
BD - Bangladesh 43
MX - Messico 38
IQ - Iraq 33
JP - Giappone 27
BE - Belgio 26
PL - Polonia 22
EC - Ecuador 21
PH - Filippine 20
LT - Lituania 19
CO - Colombia 17
ES - Italia 17
PK - Pakistan 17
UZ - Uzbekistan 16
PE - Perù 14
ID - Indonesia 13
IR - Iran 13
PY - Paraguay 13
TH - Thailandia 13
TW - Taiwan 12
RO - Romania 11
AZ - Azerbaigian 10
CL - Cile 10
VE - Venezuela 10
AT - Austria 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
KE - Kenya 8
KR - Corea 8
MA - Marocco 8
TN - Tunisia 8
BO - Bolivia 7
EG - Egitto 7
EU - Europa 7
UY - Uruguay 7
JO - Giordania 6
PA - Panama 6
GE - Georgia 5
GT - Guatemala 5
IL - Israele 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
HU - Ungheria 4
LB - Libano 4
MD - Moldavia 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
HN - Honduras 3
NO - Norvegia 3
QA - Qatar 3
AM - Armenia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
GI - Gibilterra 1
KW - Kuwait 1
Totale 16.436
Salva come PNG Salva come JPEG
Città #
Singapore 1.020
Chandler 859
Dublin 619
Ashburn 618
Jacksonville 538
Santa Clara 496
Dearborn 401
San Jose 353
Hong Kong 350
Beijing 280
Ho Chi Minh City 260
Boardman 255
Nanjing 252
Johannesburg 200
Izmir 174
Hanoi 161
Dallas 158
Princeton 154
San Mateo 147
Lauterbourg 137
Ann Arbor 122
Shanghai 114
Tito 114
Munich 106
New York 97
Toronto 86
Los Angeles 84
Shenyang 84
Wilmington 81
Nardò 73
Helsinki 70
Moscow 68
Nanchang 60
Abidjan 54
São Paulo 54
Hebei 53
Taranto 52
Genoa 48
Kunming 47
Tianjin 46
Changsha 42
Hefei 40
Jiaxing 39
Jinan 39
Buffalo 36
Da Nang 34
Turku 30
Norwalk 29
Frankfurt am Main 28
Kocaeli 26
Woodbridge 26
Brussels 25
Parma 25
Bari 22
Guangzhou 22
Haiphong 20
Houston 20
Des Moines 19
Hangzhou 19
Tokyo 19
Zhengzhou 19
Columbus 17
Denver 17
Hải Dương 17
Warsaw 17
Chicago 16
Council Bluffs 16
Montreal 16
Orem 16
Pune 16
Stockholm 16
London 15
Brindisi 14
Rio de Janeiro 14
Seattle 14
Tashkent 14
Tricase 14
Grafing 13
Belo Horizonte 12
Boston 12
Ningbo 12
Phoenix 12
Baghdad 11
Brasília 11
Bremen 11
Cambridge 11
Can Tho 11
Cascina 11
Lima 11
San Gregorio di Catania 11
Brooklyn 10
Nuremberg 10
Porto Alegre 10
Quito 10
Atlanta 9
Auburn Hills 9
Baku 9
Curitiba 9
Fortaleza 9
Lahore 9
Totale 10.016
Salva come PNG Salva come JPEG
Nome #
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 400
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 349
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 170
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 165
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 162
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 158
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 157
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 154
Association of keratin 8 gene mutation with chronic pancreatitis 153
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 152
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 151
Gastro panel® for detection of atrophic gastritis: The “Parma model” 146
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 146
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 145
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 145
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 145
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 145
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 145
Serum pepsinogen II for early assessment of success of H. pylori eradication 144
Gastrin-17 (G-17) as a sensitive serological bio-marker for diagnosis of gastro-esophageal reflux disease (GERD) independently of H. pylori status 141
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 139
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 137
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 137
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 136
T1651 The Natural History of Gastric Ulcer: A Twenty-Four Years Clinical-Endoscopical Follow-Up 135
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 135
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 133
Esophagitis: acute therapy with omeprazole (Single Dosage Versus BID) 133
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 132
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 132
OC3.07.1 CURCUMIN VS DOMPERIDON IN FUNCTIONAL DYSPEPSIA: BETTER THE PROKINETIC OR AN AGONIST OF VANILLOID RECEPTOR? 132
Pepsinogen I, II, Ratio, and G-17 in Patients With Esophagitis and Patients With Extra-Esophageal Manifestations of GERD 131
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 130
PA.6 GASTRIN-17 (G-17): A SEROLOGICAL BIO-MARKER FOR DIAGNOSIS OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD) 130
M1260 Effect of Cyclically Long-Term Treatment With Mesalamine in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD): A 5 Years Follow-up Study 128
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 128
M1141 Diagnostic Accuracy of Serum Pepsinogens and Gastrin to Follow-up Helicobacter pylori Infection: A Pilot Study 127
Gastroesophageal reflux disease in celiac patients: Preliminary results in 35 consecutive patients 127
M1262 Baseline Symptoms in Patients With Symptomatic Uncomplicated Diverticular Disease (SUDD) 126
Lactoferrin in a 1-week triple therapy for eradication of H. pylori 125
Usefulness of a serological panel test in the assessment of gastritis in symptomatic children 124
A new marker for monitoring alcohol abuse? A pilot study on heavy drinkers 124
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 122
A prospective therapeutical one-year study with pantoprazole for patients with oropharingeal picture of GERD 122
A new curcumin-based one week therapy for eradication of H. pylori infection 120
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis 119
P.1.292: SYMPTOMATOLOGICAL PATTERN IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD), IRRITABLE BOWEL SYNDROME-DIARRHOEA (IBS-D), AND IBS-D PLUS SUDD 118
“GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD 117
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 117
Serum pepsinogen II and gastrin-17 as markers of NSAIDs gastropathy 114
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 114
Chronic atrophic gastritis (GAC) and Helicobacter pylori infection eradication: a 3 years follow-up 113
P.10 “GASTROPANEL TEST” IN THE CLINICAL OUTCOME OF GERD: PROSPECTIVE SIX MONTHS CLINICAL STUDY 113
Are there useful biomarkers for gastric cancer? 111
Hypercalcemia due to ectopic secretion of parathyriod related protein from pancreatic carcinoma: a case report 111
DO PREBIOTICS RELIEVE CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-C) SYMPTOMS? A RANDOMIZED SINGLE BLINDED STUDY 110
Low alcohol and cigarette use is associated to the risk of developing chronic pancreatitis 110
Study design biases in pancreatic inflammatory diseases. 107
Lactoferrin: mechanism of action, clinical significance and therapeutic 105
Topography of gastric damage in H.pylori infection: evaluation by serum pepsinogens levels 105
Usefullness of gastropanel in different topography of H. pylori related chronic gastritis 105
PANCREATIC PSEUDOCYSTS FOLLOWING ACUTE PANCREATITIS: RISK FACTORS INFLUENCING THERAPEUTIC OUTCOMES 105
Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update 105
CORRELATION BETWEEN LACTOSE H2-BREATH TEST AND CLINICAL DATA: IS IT POSSIBLE TO SELECT PATIENTS WHO NEED LACTOSE BREATH TEST? 105
Quality of life in patients with chronic pancreatitis 104
Clinical and radiological outcome of patients suffering from chronic pancreatitis associated with gene mutations. 104
Natural course of functional dyspepsia after after helicobacter pylori eradication a 7-year survey 103
Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer 103
Assessment of H. pylori-related chronic gastritis by means of serum pepsinogens and oral sucrose 103
Italian consensus guideline for chronic pancreatitis. 102
Recovery of gastric function after H. pylori eradication in subjects with body atrophic gastritis: a prospective four years study 102
Efficacy of mesalazine in the treatment of symptomatic diverticular disease 101
Imaging of a small bowel cavernous hemangioma: report of a case with emphasis on the use of computed tomography and enteroclysis. 101
Gastroprotective effects of Amtolmetin Guacyl: a new non steroidal antiinflammatory drug that activates inducible gastric niytric oxide synthase 100
P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS 100
“The yellow stomach“: clinical relevance in endoscopical series 99
Nonteroidal drug-related gastroduodenal damage in the elderly 98
Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study 96
Therapy of NERD: single Vs double rabeprazole dosage 96
THE SIZE OF PANCREATIC PSEUDOCYST DOES NOT INFLUENCE THE OUTCOME OF INVASIVE TREATMENTS 96
TAP genes, coding for the transporters associated with antigen processing, contribute to the genetic predisposition to primary sclerosing cholangitis (PSC) 96
Rabeprazole for the treatment of oropharingeal picture of GERD: a six-month prospective study 95
Macrohematuria caused by a fall in prothrombin activity as a clinical presentation of celiac disease. (I.F. 1.357) 95
Hyperbilirubinemia: does it matter? 95
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium 94
Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels 94
Lactoferrin in a one week triple therapy for eradication of H. Pylori 94
Diagnosis of H. pylori gastritis patterns by means of gastropanel 94
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 94
Serum pepsinogen II as a biomarker in management of H. pylori infection 94
Gastropanel as screening of gastric atrophy in primary care 93
Clinical usefulness of Gastropanel (SPGI, SPGII, GASTRIN-17, HP SPECIFIC IgG) in the assessment of HP infection 93
Clinical usefulness of serum pepsinogen II in the assessment of H. pylori infection 93
Relationship between direct and indirect methods for diagnosis of H.pylori infection 93
Early epigastric pain after PPI administration: exacerbation of Helicobacter pyolori corpus gastritis? 93
Serum pepsinogen II and Gastrin-17 (G-17) as markers of NSAIDS gastropathy 92
Lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: results of an open randomized trial 92
HLA-DRB1*04 Allele contribute to the genetic susceptibility of chronic pancreatitis 92
Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. 92
GENETICS OF CHRONIC PANCREATITIS 90
Totale 12.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021173 0 0 0 0 0 0 0 0 0 32 133 8
2021/2022777 14 15 10 36 43 17 80 108 32 87 92 243
2022/20232.618 294 253 169 234 238 325 7 188 797 9 81 23
2023/2024784 53 84 24 22 56 217 40 61 18 48 77 84
2024/20253.030 83 187 214 148 364 356 36 142 452 286 219 543
2025/20265.477 515 523 519 542 853 442 640 168 858 417 0 0
Totale 16.514